Celltrion Group today announced that CT-P59, an anti-COVID-19 monoclonal antibody treatment candidate, has confirmed ...
RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies, today ...
LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell ...
The N439K mutation causes the SARS-CoV-2 virus, causal to the COVID-19 outbreak, to avoid antibodies, according to the ...
Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, announced today the development of an oral ...
As many as 230 tourism operators in West Lombok District, West Nusa Tenggara (NTB) Province, received COVID-19 vaccine ...
The Task Force for COVID-19 Handling has said that making vaccination certificates a requirement for travel would be ...
Vaccination spokesperson for the Health Ministry Dr Siti Nadia Tarmizi said the mutation of the new coronavirus N439K, ...
Winter is the beginning of the annual influenza season, and every year, in its efforts to prepare the required ...
People who receive the second dose of the coronavirus vaccine can expect their antibody level to increase to up to 99 ...
Convalescent plasma donors may emerge as game changers in the fight against the COVID-19 pandemic in Indonesia, ...
The COVID-19 Handling Task Force made an earnest appeal to survivors of the coronavirus disease (COVID-19) to come ...
With still no emergency-use approval for Sinovac’s COVID-19 vaccine, it is becoming increasingly evident that the ...
Chief of the Indonesian Red Cross (PMI), Jusuf Kalla, has urged blood donor units across Indonesian regions to collect ...
The Indonesian government is carrying out simulations to ensure the smooth implementation of its mass COVID-19 ...